MOY James N

MOY James N, a sole proprietorship based in Oak Park, Illinois, provides specialized medical expert consulting services for vaccine injury compensation claims adjudication to the Department of Health and Human Services Health Resources and Services Administration (HRSA), operating exclusively as a prime contractor on a single-customer account with total small business set-aside and competitive designations across the portfolio.

MOY James N is a for-profit sole proprietor registered as a small business in SAM.gov, with all 55 awards concentrated under a single federal customer and spanning two decades of engagement (first award March 2016, most recent September 2026). The vendor's concrete capability centers on medical case review, expert analysis of medical evidence, expert testimony, and supporting documentation for evaluating petitions and determining compensation eligibility under HRSA's Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP). Representative work includes a $37,500 total small business set-aside BPA call awarded September 2026 for medical case reviewer services (HSB114 C 7172), a $18,750 competitive set-aside BPA call from August 2025 for medical expert services (HSB114 C 6238), and a $7,500 total small business set-aside BPA call from September 2025 for medical expert services (HSB114 C 6238).

Customer concentration is absolute: HRSA Headquarters accounts for 100% of awards and combined potential value ($8.4 million across 55 awards). This single-agency dependence is the dominant characteristic of MOY James N's federal footprint — there are no secondary customers, no subcontract work, and no diversification across agencies or mission sets. The vendor operates under three active BPA vehicles. The primary vehicle, Blanket Purchase Agreement 75R60221A00082 (awarded June 2021, ceiling $249,999), has generated 33 task orders carrying $183 thousand combined potential value. A second older BPA, 75R60219A00118 (awarded 2019), supports 11 task orders with $22 thousand combined potential value. Most significantly, MOY James N was awarded a new single-award BPA on August 24, 2026 (HSB114 C 7531) with a $7.5 million ceiling and five-year performance period through August 23, 2031, explicitly extending the vendor's scope to include CICP case support alongside VICP work.

Activity has been volatile. The vendor received eight awards in 2022, four in 2023, nine in 2024, six in 2025, and two in 2026 (noting that 2026 is only partial-year data as of the source cutoff date). Combined potential value stands at $8.4 million, but only $263 thousand (3%) has been obligated across the entire portfolio, indicating that most awards carry ceiling values higher than invoiced spend. Two awards carrying combined potential value of $44 thousand face ultimate completion within the next twenty-four months, presenting a minimal recompete exposure given the large new $7.5 million BPA floor awarded in August 2026.

From a procurement categorization standpoint, all 55 awards map to NAICS 541211 (Offices of Physicians except Mental Health Specialists) and PSC L106 (Support – Professional: Expert Witness), establishing MOY James N as a pure-play medical expert witness provider to a single federal stakeholder with limited pipeline diversification but a five-year extension on its primary vehicle.